Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2003
In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5Kiran C Patki, Lisa L Von Moltke, David J Greenblatt
The Journal of Pharmacy and Pharmacology|August 3, 2004
Ethanol inhibits in-vitro metabolism of nifedipine, triazolam and testosterone in human liver microsomesKiran C Patki, David J Greenblatt, Lisa L von Moltke
AIDS Research and Human Retroviruses|July 1, 1994
Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysisM Saifuddin, M Ghassemi, C Patki, et al.
AIDS Research and Human Retroviruses|September 1, 1995
HTLV-I activates complement leading to increased binding to complement receptor-positive cellsM Saifuddin, A L Landay, M Ghassemi, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 25, 2003
Effect of age on in vitro triazolam biotransformation in male human liver microsomesKiran C Patki, Lisa L von Moltke, Jerold S Harmatz, et al.
The Journal of the Association of Physicians of India|March 7, 2001
Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregationK C Patki, S J Joglekar, S K Kamat, et al.
Molecular Genetics and Metabolism|January 13, 2019
Final results of the phase 1/2, open-label clinical study of intravenous recombinant human N-acetyl-α-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIBChester B Whitley, Suresh Vijay, Bert Yao, et al.
Ophthalmology Science|October 17, 2022
A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic AtrophyArshad M Khanani, Raj K Maturi, Nika Bagheri, et al.
Pageof 1